Compare CTBI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTBI | NNNN |
|---|---|---|
| Founded | 1903 | 2021 |
| Country | United States | Germany |
| Employees | N/A | 27 |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1995 | N/A |
| Metric | CTBI | NNNN |
|---|---|---|
| Price | $68.40 | $16.38 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $63.00 | N/A |
| AVG Volume (30 Days) | ★ 76.7K | 20.8K |
| Earning Date | 04-15-2026 | 04-07-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 17.79 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.02 | N/A |
| Revenue Next Year | $4.30 | N/A |
| P/E Ratio | ★ $45.56 | $446.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $50.25 | $10.50 |
| 52 Week High | $71.28 | $55.65 |
| Indicator | CTBI | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 33.33 |
| Support Level | $64.34 | $14.66 |
| Resistance Level | $68.49 | $31.12 |
| Average True Range (ATR) | 1.61 | 3.11 |
| MACD | -0.06 | -0.97 |
| Stochastic Oscillator | 53.27 | 9.90 |
Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).